发明申请
US20080241240A1 COMBINED PHARMACEUTICAL FORMULATION WITH CONTROLLED-RELEASE COMPRISING DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AND HMG-COA REDUCTASE INHIBITORS
审中-公开
具有包含二氢吡啶类钙通道阻断剂和HMG-COA还原酶抑制剂的受控释放的组合药物制剂
- 专利标题: COMBINED PHARMACEUTICAL FORMULATION WITH CONTROLLED-RELEASE COMPRISING DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AND HMG-COA REDUCTASE INHIBITORS
- 专利标题(中): 具有包含二氢吡啶类钙通道阻断剂和HMG-COA还原酶抑制剂的受控释放的组合药物制剂
-
申请号: US12038663申请日: 2008-02-27
-
公开(公告)号: US20080241240A1公开(公告)日: 2008-10-02
- 发明人: Sung Wuk Kim , Sung Soo Jun , Young Gwan Jo , Ja-Seong Koo , Jin Wook Kim , Ju Bin Yim , Jun Young Lee
- 申请人: Sung Wuk Kim , Sung Soo Jun , Young Gwan Jo , Ja-Seong Koo , Jin Wook Kim , Ju Bin Yim , Jun Young Lee
- 申请人地址: KR Daejeon
- 专利权人: HANALL Pharmaceutical Co., Ltd.
- 当前专利权人: HANALL Pharmaceutical Co., Ltd.
- 当前专利权人地址: KR Daejeon
- 优先权: KR10-2006-0080694 20060824; KR10-2007-0085480 20070824
- 主分类号: A61K31/44
- IPC分类号: A61K31/44 ; A61K31/454 ; A61K9/14 ; A61K9/22 ; A61P9/00
摘要:
The present invention relates to a chronotherapeutic combination pharmaceutical formulation, which is designed to control the release of each ingredient of the combined drug in a predetermined rate based on the principle of the so-called chronotherapy and xenobiotics, where drugs are administered to exhibit pharmacological activities at predetermined time intervals. The formulations of the present invention comprise a dihydropyridine, and a statin, as active ingredients. The formulations are structured and arranged such that the respective release rates of the above ingredients can be controlled, thereby reducing or preventing antagonistic effects and side effects resulting from the interaction of the above ingredients, while maintaining the synergistic effect, and providing easy medication.
信息查询